Erratum: Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients (Annals of Oncology (2001) vol. 12 (8) (1097-1106))

Creators

• Venturini M.
• Michelotti A.
• Papaldo P.
• Del Mastro L.
• Bergaglio M.
• Lionetto R.
• Lunardi G.
• Sguotti C.
• Frevola L.
• Donati S.
• Rosso R.
• Cognetti F.

Contributors